ReleaseWire

Analgesics are among the most commonly prescribed drugs for pain, especially that from fractures, ankle sprains, and other injuries. These are designed particularly for pain relief. Opioids, NSAIDs, and local anesthetics are the major analgesics used to treat pain. The long term use of analgesics has been linked to gastrointestinal problems. Pain is treated with analgesics, also called as pain killers, many of which are accessible without a prescription, including acetaminophen, aspirin, or ibuprofen. These medicines are termed as non-prescription or OTC analgesics and can be used either alone for mild pain or in combination with other medicines for severe pain.

From the moment you walk into this Compounding Pharmacy, a technician is there to greet the patient and accommodate to any needs or medical concerns that the patient may have. The pharmacy's technicians and pharmacists are devoted to providing service and care at an exceedingly high level of professionalism. This helps with the uneasiness that patients may feel when dealing with medical issues and puts them in a state of comfort. This family-owned Compounding Pharmacy near Robertson Blvd is able to provide a more personal experience with each patient that a chain pharmacy may have difficulty doing.

CEL-SCI Corporation ("CEL SCI" or the "Company") today announced that during the month of June it has enrolled 32 patients in its ongoing Phase 3 trial of its investigational immunotherapy Multikine* (Leukocyte Interleukin, Injection) in patients with advanced primary head and neck cancer. Total patient enrollment for the trial is now 848 as of June 30, 2016.

Premier Biomedical, Inc. (OTCQB:BIEI) announced today the favorable results of initial multi-faceted mouse testing of their patent pending anti-cancer antibody versus commercially available competitive drugs.  The Premier Biomedical antibody, PBI-5D3H5, demonstrated superiority based on tumor volume and mouse survivability.

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company) www.innovuspharma.com (OTCQB:INNV), a company focusing on the commercialization of over-the-counter ("OTC") and consumer products for men's and women's health, vitality and respiratory diseases, announced today, the closing of $1.5 million convertible promissory note investment from institutional investors. The convertible promissory notes have a $0.25 fixed conversion price and bear an interest rate of 10% and mature in 13 months.

GlobalData's clinical trial report, "Gastric Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Gastric Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Gastric Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GlobalData's clinical trial report, "Cervical Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Cervical Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Cervical Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GlobalData's clinical trial report, "Vascular Dementias Global Clinical Trials Review, H1, 2016" provides an overview of Vascular Dementias clinical trials scenario. This report provides top line data relating to the clinical trials on Vascular Dementias. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GlobalData's clinical trial report, "Ewing Sarcoma Global Clinical Trials Review, H1, 2016" provides an overview of Ewing Sarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Ewing Sarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GlobalData's clinical trial report, "Anal Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Anal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Anal Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GlobalData's clinical trial report, "Vaginal Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Vaginal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Vaginal Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, today announced newly available data from its successfully completed Phase III study of KIT-302 suggest beneficial effects on kidney(renal) function. Damage to renal function is a serious side effect of NSAIDs.

SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, takes a look at the underserved Female Sexual Interest Arousal Dysfunction (FSI/AD) market and Innovus Pharmaceuticals' (OTCQB:INNV) clinically proven over-the-counter treatment, Zestra®.

The global erectile dysfunction drug market is expected to reach $3.2 billion by 2022, according to Grand View Research Inc., with drugs like Viagra and Cialis leading the way. Through the use of nitric oxide conversion, these phosphodiesterase type 5 inhibitors (PDE5) based drugs increase blood flow to the penis and enable a natural erection to take place. The problem is that these drugs tend to lose efficacy over time with 40% of men stopping use of the drug.

ABC Compounding Pharmacy of Beverly Hills is considered to be one of the top-rated pharmacies that concentrates on compounded medications. Being based in Los Angeles, the Compounding Pharmacy in West Hollywood has obtained a plethora of customers who say they provide outstanding service to customers. ABC Pharmacy aims to satisfy and help the customer above all else. Because they are family-owned, they are able to provide a personal experience that is unavailable at large chain pharmacies.

Leaders in Pharmaceutical Business Intelligence (LBPI Group), launched in April 2012 as an Open Access Online Scientific Journal (http://pharmaceuticalintelligence.com), has reached over 1 million unique site visits, with approximately 30,000 monthly views, +2,115 followers, and 300 sites linking into the journal, including ncbi.nlm.nih.gov, Nature.com, commons.wikipedia.org, dx.doi.org, NEJM, personalizedmedicine.partners.org, cancer.gov, medscape.com, masspec.scripps.edu, and sciencedirect.com.

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company) www.innovuspharma.com (OTCQB:INNV), a company focusing on the commercialization of over-the-counter ("OTC") and consumer products for men's and women's health, vitality and respiratory diseases, announced today that the Company has reduced its debt obligation by $1.5 million and also eliminated approximately $300k in derivative liabilities as of 3/31/16, resulting in a total reduction of outstanding liabilities of over $1.8 million.

ABC Compounding Pharmacy is a top-tier Los Angeles Compounding Pharmacy that is now offering free delivery to local residents in the Encino area. Based in the greater Los Angeles area, ABC Compounding Pharmacy specializes in customized medications that can be modified to be just right for customers with special needs. Their compounding services are great for those that are unable to take their medications through traditional methods. The Los Angeles Compounding Pharmacy is focused on providing elite pharmacy services for every customer.

GlobalData's clinical trial report, "Myasthenia Gravis Global Clinical Trials Review, H1, 2016" provides an overview of Myasthenia Gravis clinical trials scenario. This report provides top line data relating to the clinical trials on Myasthenia Gravis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

Ampac, a division of ProAmpac, announces a new low extractable barrier lamination, PRO FlexiPURETM, which enhances the existing family of successful barrier drug and medical device overwrap laminations for the pharmaceutical and medical device markets.

ResearchPeptides.com is the world's leader in providing a forum that mainly tackles about IGF 1 and other forms of peptides available in the market. Recently, ResearchPeptides.com reveals the alarming effects and consequences of lack of insulin and IGF 1. Based on the current studies and researchers, the lack of insulin and IGF 1 has a big impact on the production of brown adipose tissue and white adipose tissue.

The global erectile dysfunction drug market is expected to reach $3.2 billion USD by 2022 according to a new report by Grand View Research Inc. Male sexual dysfunction has become a multi-billion-dollar market fueled by sales of erectile dysfunction drugs like Viagra and Cialis. In fact, Pfizer Inc.'s Viagra surpassed $1 billion in sales during its first year despite having lower than usual third-party coverage. The drug has consistently surpassed $1 billion per year in sales since its launch and even briefly reached above the $2 billion mark back in 2012 despite growing competition.

From compressing pills, to high speed bottle filling, to blister packaging, to off line inspections, conveyors have been providing reliable conveying systems for the pharmaceutical industry and providing manufacturing flexibility for contract fillers. Contract packagers often fill different products on the same line. Preventing cross contamination between products and even batches is a requirement. Hytrol offers a line of stainless steel conveyors when sanitary requirements are necessary.

Empty Capsules Market by Product (Gelatin (Porcine, Bovine, Bone Meal), Non-Gelatin (HPMC, Pullulan)), Application (Antibiotics, Vitamins, Anti-Inflammatory, Ant anemic) & End User (Pharmaceutical, Nutraceutical, Cosmetics) - Global Forecast to 2021.

GlobalData's clinical trial report, "Angioedema Global Clinical Trials Review, H1, 2016" provides an overview of Angioedema clinical trials scenario. This report provides top line data relating to the clinical trials on Angioedema. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.